Gnq Insilico

GNQ InSilico, is a cutting-edge TechBio company transforming and de-risking drug development through the convergence of AI, quantum computing and systems biology. We are accelerating the world’s transition to precision medicine by reducing the time, cost and risk of bringing drugs to market. Our breakthrough approach combines: • Proprietary multi-omic (including genomic, proteomic, metabolomic, microbiomic and epigenomic) insights at the systems biology level • Advanced AI/ML capabilities that go beyond generative AI • Quantum computing integration through planned strategic partnerships • Human Digital Twin technology for accurate drug efficacy and safety prediction What we are looking for: • Top tier scientists and engineers • Strategic partnerships with life sciences companies • Collaborations with healthcare institutions and research organizations Interested in revolutionizing drug discovery? Connect with us to explore partnership opportunities or join our mission to accelerate precision medicine. For more information, contact us at info@gnq.ai or visit our website.